Revolution Medicines, Inc. · NASDAQ:RVMD
Anders Jack sold 35,750 Revolution Medicines, Inc. shares (Form 4)
Traded Nov 11, 2026 · Filed Nov 13, 2026
On Nov 11, 2026, Anders Jack (Chief Financial Officer) sold 35,750 Revolution Medicines, Inc. shares at an average US$188.10 for US$6.72M under a trading plan, leaving 119,216 shares. Filed Nov 13, 2026 (Form 4).
- Sold
- 35,750 shares
- Price
- US$188.10 average (US$181.04 to US$192.84)
- Value
- US$6.72M
- Holding after
- 119,216 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | Common Stock | Option exercise | 15,900 | US$42.45 | 135,116 | Direct |
| Nov 11, 2026 | Common Stock | Option exercise | 19,850 | US$18.56 | 154,966 | Direct |
| Nov 11, 2026 | Common Stock | Sale | 3,499 | US$181.04 | 151,467 | Direct |
| Nov 11, 2026 | Common Stock | Sale | 5,776 | US$182.09 | 145,691 | Direct |
| Nov 11, 2026 | Common Stock | Sale | 2,700 | US$182.87 | 142,991 | Direct |
| Nov 11, 2026 | Common Stock | Sale | 1,900 | US$184.02 | 141,091 | Direct |
| Nov 11, 2026 | Common Stock | Sale | 800 | US$185.04 | 140,291 | Direct |
| Nov 11, 2026 | Common Stock | Sale | 400 | US$186.41 | 139,891 | Direct |
| Nov 11, 2026 | Common Stock | Sale | 600 | US$187.34 | 139,291 | Direct |
| Nov 11, 2026 | Common Stock | Sale | 200 | US$189.17 | 139,091 | Direct |
| Nov 11, 2026 | Common Stock | Sale | 500 | US$190.99 | 138,591 | Direct |
| Nov 11, 2026 | Common Stock | Sale | 9,486 | US$191.94 | 129,105 | Direct |
| Nov 11, 2026 | Common Stock | Sale | 9,889 | US$192.84 | 119,216 | Direct |
Source
Download original · View original at SEC
Related
- Revolution Medicines, Inc.
- Anders Jack
- Revolution Medicines, Inc. shareholders
- Form 4 · Anders Jack · Sep 18, 2026
- Form 4 · Anders Jack · Jun 26, 2026
- Form 4 · Anders Jack · Jun 18, 2026
- Form 4 · Kelsey Stephen Michael · Nov 18, 2026
- Form 4 · Borellini Flavia · Nov 17, 2026
- Schedule 13G/A · Baker Bros. Advisors LP · Nov 16, 2026
- Schedule 13G/A · Janus Henderson Group Ltd. · Nov 16, 2026
- Form 4 · Borisy Alexis · Nov 13, 2026